1[1]Noseworthy J, Gold R, Hartung HP. Treatment of multiple sclerosis:recent trials and future perspectives[J]. Curr Opin Neurol,1999,12:279. 被引量：1
2[2]Khan O, Hebel J. Incidence of exacerbations in the first 90 days of treatment with recombinant human interferon beta-1b in patients with relapsing-remitting multiple sclerosis[J].Ann Neurol,1998,44:138. 被引量：1
3[3]Bramanti P, Sessa E, Rifici C, et al. Enhanced spasticity in primary progressive MS patients treated with interferon beta-1b[J].Neurology,1998,51:1720. 被引量：1
4[4]Fazekas F, Deisenhammer F, Strasser-Fuchs S, et al. Randomized placebocontrolled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis[J]. Lancet,1997,349:589. 被引量：1
5[5]Achiron A, Gabbay U, Gilad R, et al. Intravenous immunoglobulin treatment in multiple sclerosis:effect on relapses[J].Neurology,1998,50:398. 被引量：1
6[6]Francis G, Freedman M, Antel J. Failure of intravenous immunoglobulin to arrest progreession of multiple sclerosis:a clinical and MRI based study[J]. Mult Scler,1997,3:370. 被引量：1
7[7]Barnes D, Hughes R, Morris R, et al. Randomized trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis[J].Lancet,1997,349:902. 被引量：1
8[8]Oliveri RL, Valentino P, Russo C, et al. Randomized trial comparing two different high doses of methylprednisolone in MS:a clinical and MRI study[J].Neurology,1998,50:1833. 被引量：1
9[9]Weinstock Guttman B, Kinkel R, Cohen J, et al. Treatment of fulminant multiple sclerosis with intravenous cyclophosphamide[J]. Neurologist,1997,3:178. 被引量：1
10[10]Romine J, Sipe J, Koziol J, et al. A double-blind, placebocontrolled, randomized trial of Cladribine in relapsing-remitting multiple sclerosis[J]. Proc Assoc Am Phys,1999,111:35. 被引量：1
6JOHNAS LD,FLANDERS KC,RANGES GE,et al.Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-β1[J].J Immunol,1991,147:1792. 被引量：1
7MEHROTRA PT,DONNELLY RP,WONG S,et al.Production of IL-10 by Human Natural Killer Cells Stimulated with IL-2 and/or IL-12[J].J Immunol,1998,160(6):2637-2644. 被引量：1
8KASTRUKOFF L,MORGAN N,ZECHINI D,et al.Natural killer cens in relapsing-remitting MS[J].Neurol,1999,52:351-359. 被引量：1
9STELMASIAK Z,KOZIOL-MONTEWKA M,DOBOSZ B,et al.Interleukin-6 concentration in serum and cerebrospinal fluid in multiple sclerosis patients[J].Med Sci Monit,2000,6(6):1104-1108. 被引量：1
10LOSY J,NIEZGODA A.IL-18 in patients with multiple sclerosis[J].Acta Neuro scand,2001,104(3):171-173. 被引量：1
